Literature DB >> 28169381

Direct access to the optically active VAChT inhibitor vesamicol and its analogues via the asymmetric aminolysis of meso-epoxides with secondary aliphatic amines.

Arun Sharma1, Jyoti Agarwal1, Rama Krishna Peddinti1.   

Abstract

First highly enantioselective synthesis of biologically important vesamicol, benzovesamicol, and their derivatives was achieved via the desymmetrization of meso-epoxides with secondary aliphatic amines (4-phenylpiperidine derivatives) using a chiral [salenCo(iii)-BF4] catalyst at room temperature. All products were obtained in good yield and with excellent optical induction.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28169381     DOI: 10.1039/c6ob02479c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.890


  4 in total

1.  Asymmetric Amination of meso-Epoxide with Vegetable Powder as a Low-Toxicity Catalyst.

Authors:  Yuki Takeuchi; Tatsuhiro Asano; Kazuya Tsuzaki; Koichi Wada; Hiroyuki Kurata
Journal:  Molecules       Date:  2020-07-13       Impact factor: 4.411

2.  Position 123 of halohydrin dehalogenase HheG plays an important role in stability, activity, and enantioselectivity.

Authors:  Jennifer Solarczek; Thomas Klünemann; Felix Brandt; Patrick Schrepfer; Mario Wolter; Christoph R Jacob; Wulf Blankenfeldt; Anett Schallmey
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

3.  Asymmetric ring-opening reaction of meso-epoxides with aromatic amines using homochiral metal-organic frameworks as recyclable heterogeneous catalysts.

Authors:  Koichi Tanaka; Maya Kinoshita; Jun Kayahara; Yutaro Uebayashi; Kazusada Nakaji; Maja Morawiak; Zofia Urbanczyk-Lipkowska
Journal:  RSC Adv       Date:  2018-08-06       Impact factor: 3.361

4.  A Chimeric Styrene Monooxygenase with Increased Efficiency in Asymmetric Biocatalytic Epoxidation.

Authors:  Maria L Corrado; Tanja Knaus; Francesco G Mutti
Journal:  Chembiochem       Date:  2018-03-23       Impact factor: 3.164

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.